Abstract
Two potent inhibitors of FabK, the enoyl-acyl carrier protein (ACP) reductase of Streptococcus pneumoniae, were isolated from the solid state fermentation of an unidentified fungus F010248. Their structures were identified to be atromentin and leucomelone by various spectral analysis. Atromentin and leucomelone inhibited the FabK with IC50 values of 0.24 and 1.57 μM, respectively, while did not inhibit FabI, the enoyl-ACP reductase of either Escherichia coli or Staphylococcus aureus, even at 200 μM. Atromentin and leucomelone are the first inhibitors specific to the enoyl-ACP reductase (FabK) of Streptococcus pneumoniae.
Similar content being viewed by others
Article PDF
References
Chan PF, Macarron R, Payne DJ, Zalacain M, Holmes DJ . Novel antibacterials: a genomics approach to drug discovery. Curr Drug Targets Infect Disord 2: 291–308 ( 2002)
Payne DJ, Warren PV, Holmes DJ, Ji Y, Lonsdale JT . Bacterial fatty-acid biosynthesis: a genomic-driven target for antibacterial drug discovery. Drug Discov Today 6: 537–544 ( 2001)
Zheng CJ, Yoo JS, Lee TG, Cho HY, Kim YH, Kim WG . Fatty acid synthesis a target for antibacterial activity of unsaturated fatty acids. FEBS Lett 579: 5157–5162 ( 2005)
McMurry LM, Oethinger M, Levy SB . Triclosan targets lipid synthesis. Nature 394: 531–532 ( 1998)
Rozwarski DA, Grant GA, Barton DHR, Jacobs Jr . WR. Sacchettini JC. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 279: 98–102 ( 1998)
Heath RJ, White SW, Rock CO . Lipid biosynthesis as a target for antibacterial agents. Prog Lipid Res 40: 467–497 ( 2001)
Campbell JW, Cronan Jr . JE. Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery. Annu Rev Microbiol 55: 305–332 ( 2001)
Marrakchi H, Dewolf Jr WE, Quinn C, West J, Polizzi BJ, So CY, Holmes DJ, Reed SJ, Heath RJ, Payne DJ, Rock CO, Wallis NG . Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK). Biochem J 370: 1055–1062 ( 2003)
Heerding DA, Chan G, DeWolf Jr WE, Fosberry AP, Janson CA, Jaworski DD, Mcmanus E, Miller WH, Moore TD, Payne DJ, Qiu X, Rittenhouse SF, Radosti CS, Smith W, Takata DT, Vaidya KS, Yuan CCK, Huffman WF . 1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier reductase (FabI). Bioorg Med Chem Lett 11: 2061–2065 ( 2002)
Miller WH, Seefeld MA, Newlander KA, Uzinskas IN, Burgess WJ, Heerding DA, Yuan CCK, Head MS, Payne DJ, Rittenhouse SF, Moore TD, Pearson SC, Berry V, DeWolf Jr WE . Keller PM, Polizzi BJ, Qiu X, Janson CA, Huffman WF . Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI). J Med Chem 45: 3246–3256 ( 2002)
Zhang YM, Rock CO . Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty acid synthase. J Biol Chem 279: 30994–31001 ( 2004)
Hu L, Gao JM, Liu JK . Unusual poly(phenylacetyloxy)-substituted 1,1′:4′,1″-terphenyl derivatives from fruiting bodies of the basidiomycete Thelephora ganbajun. Helv Chem Acta 84: 3342–3349 ( 2001)
Gaylord MC, Brady LR . Comparison of pigments in carpophores and saprophytic cultures of Paxillus panuoides and Paxillus atrotomentosus. J Pharm Sci 60: 1503–1508 ( 1971)
Edwards RL, Gill M . Constituents of the higher fungi Part XV. 3-(3,4-Dihydroxyphenyl)-2,7,8-trihydroxydibenzofuran-1,4-dione, a precursor of thelephoric acid from the fungus Suillus grevillei (Klotsch) sing. [Boletus elegans (Schum. Per fries)]. J Chem Soc Perkin Trans I 1975: 351–354 ( 1975)
Hwang JS, Song KS, Kim WG, Lee TH, Kohino H, Yoo ID . Polyozellin, a new inhibitor of prolyl endopeptidase from Polyozellus multiplex. J Antibiot 50: 773–777 ( 1997)
Tegos G, Stermitz FR, Lomovskaya O, Lewis K . Multidrug pump inhibitors uncover remarkable activity of plat antimicrobials. Antimicrob Agents Chemother 46: 3133–3141 ( 2002)
Takahata S, Iida M, Osaki Y, Saito Y, Saito J, Kitagawa H, Ozawa T, Yoshida T, Hoshiko S . AG205, a novel agent directed against FabK of Streptococcus pneumoniae. Antimicrob Agents Chemther 50: 2869–2871 ( 2006)
Thörner W . Ueber eigen in einer Agaricus-art vorkommenden chinonartigen Körper. Chem Ber 11: 533–535 ( 1878)
Liu JK . Natural terphenyls: Developments since 1877. Chem Rev 106: 2209–2223 ( 2006)
Brewer D, Maass WSG, Taylor A . The effect of fungal growth of some 2,5-dihydroxy-1,4-benzoquinones. Can J Microbiol 23: 845–851 ( 1977)
Khanna JM, Malone MH, Euler KL, Brady LR . Anticoagulant from Hydnellum diabolus. J Pharm Sci 54: 1016–1020 ( 1965)
Aakgi M . Pigment component of Polyporus leucomelas. I. Leucomelone, a pigment. Yakugaku Zasshi 62: 129–134 ( 1942)
Seefeld MA, Miller WH, Newlander KA, Burgess WJ, Dewolf Jr WE, Elkins PA, Head MS, Jakas DR, Jonson CA, Keller PM, Manley PJ, Moore TD, Payne DJ, Pearson S, Polizzi BJ, QIu X, Rittenhouse SF, Uzinskas IN, Wallis NG, Huffman WF . Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK. J Med Chem 46: 1627–1635 ( 2003)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zheng, CJ., Sohn, MJ. & Kim, WG. Atromentin and Leucomelone, the First Inhibitors Specific to Enoyl-ACP Reductase (FabK) of Streptococcus pneumoniae. J Antibiot 59, 808–812 (2006). https://doi.org/10.1038/ja.2006.108
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ja.2006.108
Keywords
This article is cited by
-
Culinary–medicinal mushrooms: a review of organic compounds and bioelements with antioxidant activity
European Food Research and Technology (2021)
-
Rational questing for potential novel inhibitors of FabK from Streptococcus pneumoniae by combining FMO calculation, CoMFA 3D-QSAR modeling and virtual screening
Journal of Molecular Modeling (2011)
-
Membrane lipid homeostasis in bacteria
Nature Reviews Microbiology (2008)
-
Macrolactin S, a New Antibacterial Agent with Fab G-inhibitory Activity from Bacillus sp. AT28
The Journal of Antibiotics (2008)